NEI Research News

In a University of California, Irvine-led study, researchers have discovered small-molecule drugs with potential clinical utility in the treatment of age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinitis pigmentosa (RP).

Following cataract removal, some of the brain’s visual pathways seem to be more malleable than previously thought.

A new study on herpes infections of the eye from University of Illinois Chicago researchers identifies a key protein involved in viral reinfections that could be targeted by antiviral drugs.

Study from University of Washington shows some nerve cell circuits for color vision are uniquely human.

A successful gene therapy trialed at Michigan State University in dogs with an inherited eye disease is ready to be developed for clinical use in human patients with a rare condition called retinitis pigmentosa.

Augusta University scientists have found a new target and drug that together appear to stop retinopathy of prematurity.

Syndrome is a leading cause of combined deafness-blindness

Researchers at the State University of New York help explain how reading might contribute to myopia.

New UCLA research in mice suggests that “dormant” cone photoreceptors in the degenerating retina are not dormant at all, but continue to function, producing responses to light and driving retinal activity for vision.

Using nanoparticles to encapsulate eye medication decreased graft rejection while requiring fewer and smaller doses.